MicroRNAs in Hepatocellular Carcinoma: Regulation, Function, and Clinical Implications

Overview

Journal ScientificWorldJournal

Publisher Wiley

Specialty Biology

Date 2013 Feb 23

PMID 23431261

Citations 48

Authors

Jie Sun

Haiqi Lu

Xian Wang

Hongchuan Jin

Affiliations

Soon will be listed here.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and the third cause of cancer-related death. Poor understanding of the mechanisms underlying the pathogenesis of HCC makes it difficult to be diagnosed and treated at early stage. MicroRNAs (miRNAs), a class of noncoding single-stranded RNAs of ~22 nucleotides in length, posttranscriptionally regulate gene expression by base pairing with the 3' untranslated regions (3'UTRs) of target messenger RNAs (mRNAs). Aberrant expression of miRNAs is found in many if not all cancers, and many deregulated miRNAs have been proved to play crucial roles in the initiation and progression of cancers by regulating the expression of various oncogenes or tumor suppressor genes. In this Paper, we will summarize the regulations and functions of miRNAs aberrantly expressed in HCC and discuss the potential application of miRNAs as diagnostic and prognostic biomarkers of HCC and their potential roles in the intervention of HCC.

Citing Articles

Independent prognostic significance of tissue and circulating microrna biomarkers in hepatocellular carcinoma.

Jeng L, Chan W, Teng C Discov Oncol. 2025; 16(1):281.

PMID: 40056315 PMC: 11890906. DOI: 10.1007/s12672-025-02043-y.

Shedding Light on the Molecular Diversities of miRNA in Cancer- an Exquisite Mini Review.

Venkatesh S, Manaz P, Priya M, Ambiga G, Basu S Mol Biotechnol. 2024; .

PMID: 39496855 DOI: 10.1007/s12033-024-01312-5.

Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma.

Tumen D, Heumann P, Gulow K, Demirci C, Cosma L, Muller M Biomedicines. 2022; 10(12).

PMID: 36551958 PMC: 9775527. DOI: 10.3390/biomedicines10123202.

Lipid Nanoparticle (LNP) Chemistry Can Endow Unique RNA Delivery Fates within the Liver That Alter Therapeutic Outcomes in a Cancer Model.

Johnson L, Zhang D, Zhou K, Lee S, Liu S, Dilliard S Mol Pharm. 2022; 19(11):3973-3986.

PMID: 36154076 PMC: 9888001. DOI: 10.1021/acs.molpharmaceut.2c00442.

Novel extracellular RNA biomarkers for early stage hepatocellular cancer.

Gondaliya P, Patel T ExRNA. 2022; 3.

PMID: 35874619 PMC: 9307225. DOI: 10.21037/exrna-21-23.

References

Han Z, Chen H, Fan J, Wu J, Tang H, Peng Z . Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation. J Cancer Res Clin Oncol. 2011; 138(1):153-61. DOI: 10.1007/s00432-011-1076-z. View

Orom U, Nielsen F, Lund A . MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell. 2008; 30(4):460-71. DOI: 10.1016/j.molcel.2008.05.001. View

Wang Y, Toh H, Chow P, Chung A, Meyers D, Cole P . MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB J. 2012; 26(7):3032-41. PMC: 3382089. DOI: 10.1096/fj.11-201855. View

Xu L, Qin W, Zhang H, Wang Y, Dou H, Yu D . Alterations in microRNA expression linked to microcystin-LR-induced tumorigenicity in human WRL-68 Cells. Mutat Res. 2012; 743(1-2):75-82. DOI: 10.1016/j.mrgentox.2011.12.024. View

Tsai W, Hsu P, Lai T, Chau G, Lin C, Chen C . MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009; 49(5):1571-82. DOI: 10.1002/hep.22806. View

Thomson J, Newman M, Parker J, Morin-Kensicki E, Wright T, Hammond S . Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006; 20(16):2202-7. PMC: 1553203. DOI: 10.1101/gad.1444406. View

Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S . MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med. 2009; 361(15):1437-47. PMC: 2786938. DOI: 10.1056/NEJMoa0901282. View

Rao P, Kumar R, Farkhondeh M, Baskerville S, Lodish H . Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A. 2006; 103(23):8721-6. PMC: 1482645. DOI: 10.1073/pnas.0602831103. View

Wang W, Zhao L, Tan Y, Ren H, Qi Z . MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis. 2012; 33(5):1113-20. PMC: 3334515. DOI: 10.1093/carcin/bgs113. View

10.

Shigoka M, Tsuchida A, Matsudo T, Nagakawa Y, Saito H, Suzuki Y . Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int. 2010; 60(5):351-7. DOI: 10.1111/j.1440-1827.2010.02526.x. View

11.

Law P, Ching A, Chan A, Wong Q, Wong C, To K . MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. Carcinogenesis. 2012; 33(6):1134-41. DOI: 10.1093/carcin/bgs130. View

12.

Fang J, Zhou H, Zeng C, Yang J, Liu Y, Huang X . MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology. 2011; 54(5):1729-40. DOI: 10.1002/hep.24577. View

13.

Lin C, Gong H, Tseng H, Wang W, Wu J . miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2008; 375(3):315-20. DOI: 10.1016/j.bbrc.2008.07.154. View

14.

Akkiz H, Bayram S, Bekar A, Akgollu E, Uskudar O, Sandikci M . No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study. Gene. 2011; 486(1-2):104-9. DOI: 10.1016/j.gene.2011.07.006. View

15.

Sharma A, Narain N, Handel E, Iken M, Singhal N, Cathomen T . MicroRNA-221 regulates FAS-induced fulminant liver failure. Hepatology. 2011; 53(5):1651-61. DOI: 10.1002/hep.24243. View

16.

Kim V, Han J, Siomi M . Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009; 10(2):126-39. DOI: 10.1038/nrm2632. View

17.

Kim J, Noh J, Jung K, Eun J, Bae H, Kim M . Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology. 2012; 57(3):1055-67. DOI: 10.1002/hep.26101. View

18.

Zhu X, Dong Q, Zhang X, Deng B, Jia H, Ye Q . microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. Int J Mol Med. 2012; 30(6):1321-6. DOI: 10.3892/ijmm.2012.1140. View

19.

Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J . A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer. 2010; 128(2):412-7. DOI: 10.1002/ijc.25342. View

20.

Shen Q, Cicinnati V, Zhang X, Iacob S, Weber F, Sotiropoulos G . Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer. 2010; 9:227. PMC: 2939569. DOI: 10.1186/1476-4598-9-227. View